STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

RCKT ROCKET PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

ROCKET PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to perform in line with the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive

 

Concerns

  • The multi-period measure of relative price change and consistency is well below average. Negative
  • Moving average analysis for RCKT suggests weak price movement over the medium term. Negative
  • One or more analysts has modestly decreased quarterly earnings estimates for RCKT. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 100% done.
Progress: 60% done.
Low
High

Core Model Grades

A
D
N/A
F

Previous Ratings

3
4
4